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Abstract
A relatively large number of signaling databases available today have strongly contributed to our
understanding of signaling pathway properties. However, pathway comparisons both within and across
databases are currently severely hampered by the large variety of data sources and the different levels of
detail of their information content (on proteins and interactions). In this chapter, we present a protocol for
a uniform curation method of signaling pathways, which intends to overcome this insufficiency. This
uniformly curated database called SignaLink (http://signalink.org) allows us to systematically transfer
pathway annotations between different species, based on orthology, and thereby to predict novel signaling
pathway components. Thus, this method enables the compilation of a comprehensive signaling map of a
given species and identification of new potential drug targets in humans.
We strongly believe that the strict curation protocol we have established to compile a signaling pathway
database can also be applied for the compilation of other (e.g., metabolic) databases. Similarly, the detailed
guide to the orthology-based prediction of novel signaling components across species may also be utilized
for predicting components of other biological processes.
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1 Introduction
Signal transduction pathways, functional building blocks of intra-
cellular signaling, control various cellular processes, including cell
growth, proliferation, differentiation, and stress response in diver-
gent animal phyla [1]. In humans, defects in intracellular signaling
can cause various diseases, such as cancer, neurodegeneration, mus-
cle atrophy, immune deficiency, or diabetes. Therefore, a better
understanding of the structure, function, and evolution of signal
transduction is important for both basic research and medicine.
This requires the construction of a comprehensive signaling map,
which would (ideally) contain all components of distinct signaling
pathways and their genetic and physical interactions. Genome pro-
grams and high-throughput (HTP) protein–protein interaction
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analyses have greatly contributed to the construction of signaling
maps in various model organisms, ranging from invertebrates
to mammals. Accordingly, the effort to map novel signaling
components and interactions has largely benefited from network
alignment techniques and other widely used functional genomics
methods, allowing the integration of functional data among and
within species [2, 3].
Most of these methods predict new gene or protein
properties (annotations) on the basis of sequence homology and
similarities between known functions. Similar annotation transfer
approaches have been applied to predict structural properties (e.g.,
domain composition), expression profiles, and physical interactions
of proteins [4–6]. For predicting interactions, several techniques
have been suggested, out of which one of the most widely used is
the method of “interologs”: two proteins are predicted to physi-
cally interact with each other, if their orthologs in another organism
also interact [7]. Interologs, however, are found to be less con-
served than orthologs [8] and also less reliable than interactions
generated by HTP approaches [9].
Despite a great wealth of protein interaction data obtained
from HTP experiments, such as yeast two-hybrid screens, the low
abundance of extracellular, membrane-bound, and nuclear signal-
ing components (e.g., ligands, receptors, and transcription factors)
make these experimental techniques only partially efficient for
identifying signaling interactions [10]. Accordingly, several signal-
ing pathway databases have been generated manually by collecting
relevant data from the literature [11]. However, so far most of them
lack those key features (e.g., uniform pathway curation across more
than one species) that would be necessary for transferring signaling
pathway membership information between species [10]. Reliable
and detailed signaling pathway databases are crucial for predicting
novel signaling components because they are needed (1) as sources
of known pathway information from which prediction can be per-
formed (i.e., seed data) and (2) as reference data sets against which
the novelty of predictions can be tested (i.e., those predicted sig-
naling pathway member proteins that are already known pathway
members should be removed from the list of predictions, while
others can be regarded as predicted components).
A comprehensive pathway resource, SignaLink, developed in
our lab, applies uniform curation rules to keep the levels of detail
identical in all examined pathways for Caenorhabditis elegans,
Drosophila melanogaster, and humans [12]. Compared to three
widely used pathway databases (KEGG, Reactome and NetPath),
SignaLink contains the (1) highest numbers of signaling proteins
and interactions; (2) highest numbers of signaling cross-talks and
multi-pathway proteins; (3) and above the average number of
publications used per pathway [12]. Moreover, the uniform cura-
tion protocol and data structure of the SignaLink database allow
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systematic transfer of pathway annotation between two species on
the basis of sequence orthology.
The topology of signaling pathways is crucial for selecting
possible novel drug target candidates [13]. As an example, drugs
used for inhibiting a specific signaling protein in order to affect
proliferation may actually activate the corresponding pathway by
triggering an unknown negative feedback loop [14]. Transferring
signaling pathway annotations across species may alleviate such
difficulties and can provide a more comprehensive signaling net-
work. Identification of novel signaling components may help to
discover novel drug targets as (1) these signaling components can
increase the applicability of model organisms for testing drugs and
drug target candidates, (2) in humans, they can serve as potential
novel drug targets, and (3) in the case of already used target
proteins they can help to uncover possible side effects.
2 Materials
1. The data serving as a basis for building the SignaLink database
were obtained from both review papers and primary research
articles (see Table 1).
2. These were complemented with data derived from species-
specific databases for Drosophila and C. elegans (Flybase and
Wormbase, respectively) that contain information from differ-
ent sources—ranging from large-scale experiments to primary
research articles (see Table 1).
3. We collected Ensembl IDs for human proteins from the
genome browser Ensembl and ORFs for worms and flies
from species-specific databases (Flybase and Wormbase),
while UniProt IDs were collected from UniProt for all three
species (see Table 1).
Table 1
Sources of the manually curated SignaLink database
Source Protein Signaling interaction Link Reference
170 Review papers ✓ ✓
771 Research articles ✓ ✓
Wormbase ✓ ✓ http://www.wormbase.org/ [37]
Flybase ✓ ✓ http://flybase.org/ [32]
UniProt ✓ http://www.uniprot.org/ [29]
Ensembl ✓ http://www.ensembl.org/ [24]
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4. We searched directly for suggested interactions between two
selected proteins with iHOP andChiliBot [15, 16] (seeTable 2).
iHOP uses genes and proteins as hyperlinks between sentences
and abstracts, meaning that information of a single protein and
its interaction is given as a sentence retrieved from source
abstracts [16].
5. We also used the synonym identification tool of iHOP for
collecting protein synonyms.
3 Methods
In this section, we describe a unified curation protocol for assigning
signaling proteins to signaling pathways and for compiling signal-
ing interactions within a pathway. This standardized curation pro-
tocol in three different organisms is a prerequisite for enabling
systematic transfer of pathway annotations between different spe-
cies to predict new signaling components based on orthology.
3.1 Creating a
Signaling Database
(SignaLink) by a
Uniform Manual
Curation Protocol
The following section describes our workflow for the construction
of a signaling database, which contains eight pathways in three
species (see Fig. 1). The main steps involve listing signaling proteins
of the given pathways, collecting information on the proteins,
assigning each protein to the region/section of a given pathway,
and collecting protein interaction information of the proteins,
thereby also compiling additional proteins to the pathway.
3.1.1 Collecting Pathway
Information for Signaling
Proteins
All pathways examined from three species (C. elegans,D.melanogaster,
and Homo sapiens) were compiled (i.e., manually curated) separately.
For the challenges and importance of pathway definitions, seeNote 1.
For each pathway, three main steps were performed:
1. A search for pathway-specific review articles and databases
using PubMed, Google Scholar, and Google.
2. The assignment of signaling proteins to signaling pathways
based on the full text of reviews.
Table 2
Search engines used for the compilation of SignaLink
Search
engines Protein
Signaling
interaction Link Reference
iHOP ✓ ✓ http://www.ihop-net.org/ (18)
Chilibot ✓ ✓ http://www.chilibot.net/ (15)
PubMed ✓ http://www.ncbi.nlm.nih.gov/pubmed/
InParanoid ✓ http://inparanoid.sbc.su.se/ (17)
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Fig. 1 Manual curation process of SignaLink. To compile the SignaLink pathway resource [12] (http:/signalink.org),
signaling interactions were collected from pathway reviews, species-specific databases, and UniProt. Only inter-
actionswith referenceswere included aftermanual checks via PubMed. The iHOP and ChiliBot search engineswere
used for finding references for suggested interactions lacking a reference in the reviews, and these search results
were also manually checked. Synonyms for the interacting proteins were obtained with the help of the synonym
finder tool of iHop. Finally, curated signaling proteins were assigned to pathway regions and pathway sections
3. An extended search for additional pathway proteins using
iHOP and ChiliBot [15, 16].
4. When inserting a protein into SignaLink we assigned it to one
pathway and—within this pathway—to one pathway region.
Later, further pathways and pathway regions were added for
this protein, if necessary. We marked a protein as a “core”
component of a pathway, if it is essential for transmitting the
signal of its pathway and has at least one of the pathway’s
biochemical characteristics, e.g., “Ser/Tyr-kinase activity”.
A “non-core” (or “peripheral”) component modulates the
pathway’s core proteins, but it does not participate directly in
the transduction of the signaling flow.
5. Additionally, the pathway section(s) of each protein was deter-
mined separately and a maximum of two sections per protein
were allowed. The pathway position ligand indicates that the
given protein initiates the signal of its pathway. A receptor is
the direct receiver of this signal. A mediator is a member of the
pathway that transduces the signal from the receptor towards
downstream transcription factors. A co-factor modulates the
function of any other protein from the pathway. Notably, co-
factors often reside in the peripheral (non-core) region of their
pathways. A transcription factor (1) activates another transcrip-
tion factor (TF) after receiving the signal from its pathway, or
(2) forms a complex with other TF proteins, or (3) binds to a
specific promoter region (i.e., a specific binding site) on the
DNA. Non-signaling proteins with roles in cellular motion,
transport, and membrane anchoring were marked as other.
When information on the position of a signaling protein in its
pathway was lacking, the protein was marked unknown.
3.1.2 Collecting
Signaling Protein
Information
After listing pathway proteins from review and research papers,
information on the signaling proteins were collected from different
databases (see Table 1). For each protein, we also listed its ortho-
logs in the other two species with the help of the ortholog clusters
of the InParanoid database [17]. During collecting UniProt IDs,
if more than one UniProt ID were available for the same protein,
then the ID(s) of the protein(s) with the longest amino acid
sequence was (were) used. To make the database more comprehen-
sive, we assigned all known synonyms of the proteins. These were
listed from review papers, and the “synonym” field of the iHOP
database [18]. For the conversion of protein IDs, the Protein
Identifier Cross-Reference Service (PICR) [19] and Synergizer [20]
were used.
3.1.3 Collecting
Signaling Interaction
Information
A key feature of a signal transduction network is that the direction
of an interaction is well distinguishable (e.g., protein A activates or
negatively regulates protein B). Accordingly, all interactions
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inserted into SignaLink had to be directed. Each interaction had
to be documented with the PubMed ID of the publication report-
ing the verifying experiment(s). Signaling interactions of a protein
were collected from primary research articles, listed in review
papers, species-specific databases (FlyBase, WormBase), and Uni-
Prot, iHOP, ChiliBot, and PubMed search results (see Tables 1
and 2). All research articles were manually examined, and in terms
of biochemical experimental evidence, we marked every protein
interaction as either direct or indirect. Direct experimental evidence
indicates that there is a published biochemical evidence for sig-
naling interaction between two given proteins, whereas indirect
experimental evidence indicates that there is no direct biochemical
evidence for interaction, but published experimental results suggest
that interaction is very likely possible. Evidence types accepted here
involve (1) changes in mRNA/protein levels, enzyme activities,
concentrations of the products of catalyzed reactions, and (2) dock-
ing domain structures.
Importantly, not only the direction, but also the effect of an
interaction is highly relevant to a signaling database. All interactions
can be characterized as activating or inhibitory.
For interactions with indirect evidence, we marked activating
interactions as ++ and , while inhibitory interactions were
marked + and +. A unidirectional interaction (A and B interact
as either A!B or B!A) has only one type of effect, but for the few
bidirectional interactions (A!B and B!A are both present) more
than one type of effects are possible between the two proteins. Two
signaling interactions between the same two proteins in opposing
directions are listed separately in SignaLink. For the challenges and
limitations of manual curation, see Note 2.
3.1.4 Curation Process
Example: The Notch
Signaling Pathway and
the NOTCH1 Protein
As an example, we present here the human Notch pathway and one
of its components, the human NOTCH1 receptor protein. We
describe the process of (1) obtaining information for the
protein NOTCH1 and (2) obtaining protein interaction informa-
tion for NOTCH1.
According to pathway-based reviews [21], there are 4 members
of Notch receptor family proteins in humans: NOTCH1,
NOTCH2, NOTCH3, and NOTCH4. Notch proteins have a
specific role in transmitting signals [22] between ligands and tran-
scription factors, as well as several additional proteins which influ-
ence the function of Notch proteins [23].
Alternative splicing can generate functionally different pro-
teins from the same coding region; however, in the majority of
proteins functional significance of different splice variants remains
unknown. Despite their potentially different roles, databases and
review papers do not differentiate between splice variants. For the
human NOTCH1 protein, Ensembl [24] contains two splice var-
iants: ENSP00000277541 and ENSP00000360765. From these
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two, the InParanoid database [17] contains only the first,
ENSP00000277541. Therefore, we inserted only this splice variant
into SignaLink. For proteins that have more than one splice variant,
but none of them is present in the InParanoid database, we inserted
into SignaLink the splice variant that has a primary UniProt acces-
sion (AC), as listed by Ensembl version 49.
From Ensembl, we included into SignaLink the UniProt
accession(s) of a protein, and from UniProt we used the following
data fields of the protein: description, reference—if it contained
interaction data,—and cellular component. In addition, data from
protein description and interaction fields were manually tested in
primary publications for further information.
Regarding the region/section, NOTCH1 is a core protein of
its pathway and functions as a receptor, mediator, or transcription
factor, according to ref. [25]. However, within the Notch pathway,
NOTCH1 functions either as a receptor or a transcription factor.
Thus, we included only these two pathway sections for NOTCH1-
into SignaLink.
To make SignaLink as complete as possible, we searched for
orthologs of the human NOTCH1 protein. Orthologs without
known signaling interactions became predicted pathway proteins
in SignaLink. From the InParanoid database we identified the
C. elegans and D. melanogaster orthologs of human NOTCH1
(ENSP00000277541). (In several cases we searched by both the
UniProt and Ensembl protein IDs in InParanoid to find the pro-
tein.) Interestingly, the human NOTCH1 has two worm orthologs
(LIN-12 and GLP-1), but only one fly ortholog (the protein N).
We inserted all three orthologs into SignaLink. We listed species-
specific protein IDs and UniProt ACs of the orthologs from
WormBase and FlyBase. For ligands and transcription factors inter-
acting with NOTCH1, we followed the same steps.
Next, we listed articles describing signaling interactions
between NOTCH1 and other proteins by browsing through the
references of the above mentioned review papers and by using
the search engines iHOP [18] and ChiliBot [15]. iHOP allows
users to search for all abstracts with interactions containing
NOTCH1. With ChiliBot the interaction between two selected
proteins can be directly searched for. As an example, interaction
between NOTCH1 and TACE/ADAM17 has been described in an
experimental article [26]. After reading the article, we found that it
describes (1) a putative cleavage site for TACE on NOTCH1 and
(2) a correlation between the in vitro enzymatic activity of TACE
and the activity of NOTCH1. Thus, this article provides evidence
for the activation of NOTCH1 by TACE. In addition, we directly
searched for interactions between the orthologs of TACE and
NOTCH1 in the other two species.
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3.2 Signalog
Prediction Based on
Orthologous Signaling
Components
Despite the conservation of many biological processes (e.g., devel-
opmental signaling pathways) throughout evolution, there is a poor
overlap in protein–protein interactions between species in different
databases [27]. Furthermore, the catalogue of proteins annotated
with signaling function is incomplete even in highly studied model
organisms. Therefore, the prediction of new potential signaling
interactions and also new signaling proteins based on orthology is
an important task.
3.2.1 Prediction
of Signalogs
We started with creating a list from the three species examined in
SignaLink (C. elegans, D. melanogaster, and H. sapiens) by collect-
ing those proteins that have no known signaling interactions, but
have at least one signaling pathway member ortholog in the other
two species. Similarly to the concept of functional orthology [28],
for each of these proteins we assumed that their pathway annota-
tions (i.e., signaling role) can be transferred between species. Thus,
we predicted that a protein is a member of the same signaling
pathway(s) in which its ortholog(s) belong(s) (see Fig. 2). These
proteins were termed as signalog proteins (signalogs). Because in
SignaLink a protein can belong to more than one pathway [12], a
signalog can also be annotated to more than one pathway. Using
this approach we were able to predict 88, 92, and 73 novel signaling
proteins in worms, flies, and humans, respectively [10]. For the
limitations of orthology-based pathway annotation transfer,
see Note 3.
Creating the Signalog confidence score
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Ortholog proteins with 
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Ortholog proteins 
without known 
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annotation 
transfer
Signalog of pathway A 
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Pathway membership examination of the
neighbor(s) of the protein
whose ortholog is a signalog
(e.g., pathway membership examination of Protein Z)
Pathway membership examination of the
ortholog(s) of the neighbor(s) of the protein
whose ortholog is a signalog
(e.g., pathway membership examination of Protein Z’)
Signalog confidence score:
Based on the Spearman rank correlation of the 
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between the pathways of the neighbor(s) of 
the original protein (Protein Z) and the  
pathways of its (their) ortholog (Protein Z’).
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memberships of all proteins 
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Predicting Signalogs from SignaLink
Fig. 2 Prediction of signalogs and calculation of the signalog confidence score. Based on the SignaLink
resource [12] orthology assignment was performed between each pair of the three species. Proteins were
predicted to be members of the same signaling pathway(s) where their orthologs belong. An interaction with a
signaling protein Z0 was predicted for a protein, if the ortholog of the protein interacted with Z (the ortholog of
Z0) in the same pathway A in a different species. A confidence score was calculated based on the pathway
membership similarity between the neighbors of Z and its ortholog Z0. See main text for details
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3.2.2 Defining the
Novelty of Signaling Protein
Predictions Based on
Orthology
To verify the novelty of the predicted signaling roles which have not
been featured in other resources yet, we searched the literature with
semiautomated methods for already known annotations. Next, we
compared the list of signalogs and their predicted pathway mem-
berships to pathway annotations found in pathway databases, as
well as the list of ortholog predictions to previously published
interolog predictions. To assess the novelty of signalogs and
quantify the confidence level of each prediction, we performed
semiautomated searches using PubMed, UniProt, GO, Wormbase,
FlyBase, iHOP, and Chilibot web services [15, 18, 29–32]. During
this process, direct manual curation and Python scripts checking
multiple proteins in one webservice were used. In each of the three
species examined, we classified the predicted signalogs into five
groups on the basis of their known properties in the literature: (1)
no orthology information and/or no biochemical function is avail-
able; (2) there are known orthologs with unknown biochemical
function; (3) only biochemical function is available, but orthology
information is lacking; (4) data on orthology as well as biochemical
function(s) exist; (5) orthologs, biochemical function(s), and path-
way annotation(s) are all known. Categories 1–5 denote a decreas-
ing level of novelty. However, even category (5) contains signalogs
for which at least one novel signaling pathway membership is
predicted. Additionally, to check the novelty of the predicted sig-
naling pathway memberships, we compared the list of signalogs and
their predicted pathway memberships to known pathway member-
ship annotations from Reactome and KEGG [33, 34]. We next
applied interologs to verify the novelty of our ortholog predictions
(an interolog is a pair of proteins predicted to interact based on the
interaction of the two proteins’ orthologs in at least one other
organism) [7]. To reveal the presence of signalogs in current
orthology-based prediction databases, we compared already iden-
tified interologs in worms, flies, and humans using three species-
specific datasets (WI8, DroID, and HomoMINT) [8, 35, 36] with
interologs generated from SignaLink data. Since neither SignaLink
[12] nor the current signalog identification approach identify inter-
ologs directly, we used an indirect method by first deducing
interologs from SignaLink data: we linked two proteins in an
organism, if their orthologs interacted in at least one of the other
three organisms. After generating all possible interologs from Sig-
naLink, we examined only those (predicted interactions) in which
at least one of the interactors is a signalog protein (predicted
signaling pathway member).
3.2.3 Creating
a Confidence Score
for Signalogs
To assess the reliability of a signalog, a confidence score was calcu-
lated in each case (see Fig. 2). For the signalog Z0 that was predicted
to be a component of Pathway A0 (PA0) in Species 2, we examined
pathway membership of each neighbors (protein interactors) of Z0
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in Species 2 and the known signaling component, Z in Species 1.
For each Z and Z0 proteins, we summed pathway memberships as
2 pathway vectors (Vector_Z and Vector_Z0). Vectors have compo-
nents indexed with the name of their signaling pathways. Finally, we
computed the Spearman rank correlation of vectors computed for
Z and Z0, and based on this correlation we defined the Signalog
confidence score: [(Spearman_corr + 1)/2] * 100. This confidence
score quantifies similarity between the signaling pathway member-
ship profile of the possible interactors of a signalog protein and
the original signaling protein (i.e., the orthologs of the signalog
protein). Predictions above 50% can be considered as confident
predictions.
4 Notes
1. Pathway definition is a critical task when compiling a pathway
database. Pathway databases tend to use different pathway
definitions, such as:
l Canonical (e.g., MAPK)
l Functional (e.g., inflammation)
l Inferred (e.g., from gene expression data)
l Cellular process regulating (e.g., autophagy induction)
l Organ-related (e.g., vulva development)
l Disease-related (e.g., list of connected proteins affected
by mutations in breast cancer; Alzheimer’s disease)
l Drug-related (e.g., pharmacologically affected list of
connected proteins)
To develop a database for comparative purposes or systems-
level examinations, pathway definitions must be the same in the
whole database. For SignaLink, we applied a biochemically
based, well-documented, and clear pathway definition. For
example, the EGF/MAPK pathway in SignaLink contains
(with evolutionary and biochemical reasoning) the pathway
from the EGF ligand to the terminal MAPK kinases. In several
other databases this pathway is scattered across many separate
(sub)pathways (e.g., EGFR, RAS, p38, JNK, ERK, ASK).
An important consequence of precise pathway definitions is
the reduced number of examined pathways. An appropriate
and precise grouping can be important to avoid artificial path-
way constructs [12].
2. Despite recent advances in the technology of manual pathway
curation, this technology still does have several limitations.
First, curation highly depends on the knowledge and back-
ground of the curator as well as on the quality of the protocol
Curation and Prediction of Signaling Networks 295
used for the curation [9]. Second, all data are based on the
actual knowledge from the literature. Therefore, these data-
bases have to be updated regularly (e.g., annually or bi-anually).
3. According to our current knowledge, the limitations of
systematical pathway annotation transfer between species are
the following. Interactions of membrane-bound and nuclear
proteins are still underrepresented in most databases, thus pre-
dictions involving these proteins are less reliable. Furthermore,
interactions between signaling proteins have been shown to be
generally more unique to their species than PPIs in most
biological processes [7].
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